Roger Gooding
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
-
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Immune Cell Function and Interaction
Papers in
-
- Multiple Myeloma Research and Treatments 4
- Hematopoietic Stem Cell Transplantation 2
-
- Cell Adhesion Molecules Research 2
- Co-authors
- P G RichesAnthony W. RowbottomBarbara C. MillarE HeydermanXin HanJ R HobbsAdrian F. BristowJane F. Apperley
- Journals
- British Journal of Haematology (5 papers)Journal of Pharmacy and Pharmacology (1 paper)British Journal of Cancer (1 paper)Clinical Chemistry (1 paper)Cytokine (1 paper)
- Partner nations
- United KingdomGermany
In The Last Decade
Roger Gooding
17 papers receiving 567 citations
Peers
Comparison fields: 5 of 83
- Hematology 148
- Immunology 192
- Oncology 175
- Genetics 60
- Biological Psychiatry 13
Countries citing papers authored by Roger Gooding
This map shows the geographic impact of Roger Gooding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Gooding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Gooding more than expected).
Fields of papers citing papers by Roger Gooding
This network shows the impact of papers produced by Roger Gooding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Gooding. The network helps show where Roger Gooding may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger Gooding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 32 | |
| 2 | 1998 | 30 | |
| 3 | 1997 | 36 | |
| 4 | 1997 | 1 | |
| 5 | 1995 | 65 | |
| 6 | 1995 | 55 | |
| 7 | 1994 | 3 | |
| 8 | 1993 | 108 | |
| 9 | 1993 | 38 | |
| 10 | An assessment of myeloid colony-forming-cell generation in liquid human bone marrow cultures: influence of accessory cells and cytokines IL-1 alpha, beta and IL-6. | 1993 | 1 |
| 11 | C-reactive protein and its cytokine mediators in intensive-care patients. | 1993 | 39 |
| 12 | 1992 | 2 | |
| 13 | 1992 | 110 | |
| 14 | Comparison of interleukin-6 levels in the bone marrow of multiple myeloma patients with disease severity and clonogenicity in vitro. | 1991 | 5 |
| 15 | 1990 | 20 | |
| 16 | 1990 | 31 | |
| 17 | 1985 | 10 |
About Roger Gooding
Roger Gooding is a scholar working on Hematology, Immunology and Allergy, Immunology, Emergency Medicine and Genetics, having authored 17 papers that have together received 586 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), T-cell and B-cell Immunology (3 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers), Pancreatitis Pathology and Treatment (2 papers), Cell Adhesion Molecules Research (2 papers), Hematological disorders and diagnostics (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Hematology (148 citations), Immunology (192 citations), Oncology (175 citations), Genetics (60 citations) and Biological Psychiatry (13 citations). Roger Gooding has collaborated with scholars based in United Kingdom and Germany. Frequent co-authors include P G Riches, Anthony W. Rowbottom, Barbara C. Millar, E Heyderman, Xin Han, J R Hobbs, Adrian F. Bristow, Jane F. Apperley, John M. Goldman and M. Gore. Their work appears in journals such as British Journal of Haematology, Journal of Pharmacy and Pharmacology, British Journal of Cancer, Clinical Chemistry and Cytokine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.